Pathoquest

Your GMP Next-Gen Biosafety Partner.
PathoQuest is a global CRO providing NGS-based Biosafety Quality Control through its iDTECT platform.

[Pathoquest @Pathoquest]

📢 Watch the replay!
AFSA has shared the recording of our joint webinar on how next-generation sequencing supports biopharmaceuticals animal-free viral safety assessment.
Catch up on the key insights and discussions you may have missed.
▶️ Replay available via AFSA’s post

[Animal-Free Safety Assessment (AFSA) Collaboration @AFSAcollab]

Thanks to everyone who joined our webinar, “Biopharmaceuticals Animal-Free Viral Assessments,” with @Pathoquest.

And thanks to Colette Cote for sharing case studies & regulatory insights on Next-Gen Sequencing in biosafety testing.

Watch the recording:
https://t.co/Yclv8RHOwP

[Pathoquest @Pathoquest]

Today, we want to reaffirm our commitment to support faster and safer access to innovative cancer treatments by providing advanced NGS-solutions for the quality control of biologics.
#WorldCancerDay #IamAndIwill
https://t.co/OAhTRdh5oY

[Pathoquest @Pathoquest]

They talk about us 📢 https://t.co/bYIwSZEjnA via @rmb

[Pathoquest @Pathoquest]

Our NGS-based approach provides a state-of-the-art quality control testing solution for biopharmaceutical quality assurance and production managers. Our new facility in Wayne will create additional opportunities to integrate with Charles River’s service... https://t.co/7NkoTf78Gj

[[iito] Life Science @iitoLifeScience]

PathoQuest obtains Pharmaceutical Establishment status from French ANSM to meet big pharmas’ expectations for the quality control of biologics https://t.co/8mo5aPKKsz @Pathoquest More French life science business news at [LSF] at https://t.co/c1gLDUXB8r

[Pathoquest @Pathoquest]

PathoQuest obtient le statut d’Établissement Pharmaceutique par l’ANSM pour le contrôle qualité des biomédicaments https://t.co/TS8ZfGdh4u

[Pathoquest @Pathoquest]

In a thriving effort to enhance its customer services, PathoQuest has obtained the administrative authorization of the Pharmaceutical Establishment from the French ANSM for its biological drug testing activities.
Read the full press release: https://t.co/uqvrh6UVDi
#ngs #qc

[Pathoquest @Pathoquest]

Don't' miss our 2 talks today during the Viral safety session:
*11:40 Dr.Magali Roche - NGS capabilities in term of Biologics QC testing
*13:40 Pr.Marc Eloit - NGS innovations for Mycoplasma detection
Free passes here>> https://t.co/7hLQjNbAin
#BPIEUROPE

[Pathoquest @Pathoquest]

You can reach our team on our virtual booth Audrey Coiffic and Magali Roche. And don’t miss Dr.Roche’s talk on NGS capabilities in term of Biologics QC testing Thursday 16 July 20 Free pass here >> https://t.co/TgPmPyDK2C
#BPIEUROPE

[Pathoquest @Pathoquest]

Come exchange with our experts on our virtual BPI booth this week and don’t miss Dr. Marc Eloit talk on Thursday. Free passes here>> https://t.co/HCzK6CmlNH
#BPIEUROPE

[Pathoquest @Pathoquest]

Should your QC program compromises between speed and robustness? Learn how NGS is the right tool to ensure your biologics safety & efficacy with Dr.Magali Roche's talk at BPI (16 July 20)
Get your free virtual exhibition pass (13-17 July 20) >> https://t.co/HCzK6CmlNH

#BPIEUROPE

[Pathoquest @Pathoquest]

Want to learn more about NGS innovations for Mycoplasma detection? Get your free virtual exhibition pass to next BPI event (13-17 July 20) >> https://t.co/HCzK6CmlNH
#NGS #BPIEUROPE

[Pathoquest @Pathoquest]

PathoQuest Announces Appointment of Laurent Lafferrere as Chief Operating Officer >> https://t.co/SIhhGk4erH

[Pathoquest @Pathoquest]

@TransgeneSA chooses @Pathoquest innovative NGS-based safety release test for TG4050 phase I clinical trial targeting patients with head-neck and ovarian cancers and for Invir IO™ recombinant viral vector manufacturing platform
>> https://t.co/OrgHyQE8ZL #NGS #QC

[Pathoquest @Pathoquest]

PathoQuest’s Paris-based facility obtains GLP certificate for its biologics genomic quality control testing service. PathoQuest is the first company in France to receive such a certificate from the ANSM for advanced NGS viral safety testing. Full PR >> https://t.co/XVhldOCbIm

[Pathoquest @Pathoquest]

PathoQuest is proud to again be a sponsor of the International Conference on Clinical Metagenomics. The 4th Edition of this meeting (ICCMg4) is being held 17-18 October 2019 in Geneva, Switzerland. https://t.co/8dd7FkqwVQ #ngs #metagenomics @IccMg

[Pathoquest @Pathoquest]

PathoQuest's CEO Jean-François Brepson discusses the company's efforts with iDTECT Blood in a new Illumina Genomics Podcast "NGS and New Frontiers in Infectious Disease" https://t.co/mqbkcMvDbO (Episode 53) #NGS #illumina #antimicrobialresistance #antibioticstewardship

[Pathoquest @Pathoquest]

PathoQuest Secures 8 Million Euros in New Financing https://t.co/bNX37J1qNY

[Pathoquest @Pathoquest]

Register for our upcoming September 10th webinar: Cell Testing for Adventitious Viruses: A Game Changing Approach using High-Throughput Sequencing @ https://t.co/TIKkpn2S2V #PathoQuest #BGS #NGS

[Pathoquest @Pathoquest]

PathoQuest Announces Appointment of Patrick Court as Chief Financial Officer https://t.co/fgjKMXhKX1